Tudor Investment Corp’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-225,097
| Closed | -$3.37M | – | 3122 |
|
|
2022
Q4 | $3.37M | Buy |
+225,097
| New | +$3.12M | 0.07% | 375 |
|
|
2017
Q2 | – | Sell |
-8,387
| Closed | -$49K | – | 1522 |
|
|
2017
Q1 | $49K | Hold |
8,387
| – | – | ﹤0.01% | 1332 |
|
|
2016
Q4 | $45K | Hold |
8,387
| – | – | ﹤0.01% | 1337 |
|
|
2016
Q3 | $75K | Hold |
8,387
| – | – | ﹤0.01% | 1360 |
|
|
2016
Q2 | $81K | Hold |
8,387
| – | – | ﹤0.01% | 1531 |
|
|
2016
Q1 | $77K | Hold |
8,387
| – | – | ﹤0.01% | 1633 |
|
|
2015
Q4 | $106K | Hold |
8,387
| – | – | ﹤0.01% | 1528 |
|
|
2015
Q3 | $101K | Buy |
8,387
+158
| +2% | +$2.28K | ﹤0.01% | 1427 |
|
|
2015
Q2 | $143K | Sell |
8,229
-593
| -7% | -$10.7K | ﹤0.01% | 1386 |
|
|
2015
Q1 | $128K | Hold |
8,822
| – | – | ﹤0.01% | 1358 |
|
|
2014
Q4 | $74K | Sell |
8,822
-1,110
| -11% | -$10.2K | ﹤0.01% | 1378 |
|
|
2014
Q3 | $110K | Sell |
9,932
-738
| -7% | -$9.38K | ﹤0.01% | 1271 |
|
|
2014
Q2 | $195K | Hold |
10,670
| – | – | 0.01% | 1055 |
|
|
2014
Q1 | $160K | Sell |
10,670
-240
| -2% | -$4.31K | 0.01% | 1075 |
|
|
2013
Q4 | $200K | Buy |
+10,910
| New | +$218K | 0.01% | 1110 |
|
|
2013
Q3 | – | Sell |
-11,130
| Closed | -$278K | – | 1013 |
|
|
2013
Q2 | $278K | Buy |
+11,130
| New | +$476K | 0.02% | 592 |
|
Tudor Investment Corp's AVEO Position: Q1 2023 in Review
Tudor Investment Corp sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 225,097 shares — an estimated $3.37M sold.
Tudor Investment Corp first reported a position in AVEO in Q2 2013 and held it in 16 quarters. The position peaked at $3.37M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Tudor Investment Corp reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Tudor Investment Corp sold 225,097 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $3.37M.
- Tudor Investment Corp first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
- Tudor Investment Corp's AVEO Pharmaceuticals, Inc. position peaked at $3.37M in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.